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Antibody identification is one of the last areas of laboratory 
medicine to embrace computerization. This is due in part to the 
complex nature of antibody identification. Until recently, com- 
puter programs written to assist with antibody identification have 
been slow and cumbersome. However, technological advances in 
computer hardware have greatly improved the response time for 
these applications. Still, blood bank technologists sometimes 
shun assistance from the computer because they consider anti- 
body investigation as an intellectually stimulating aspect of their 
job that they do not wish to turn over to a computer. Computer 
programs for antibody investigation are probably most useful for 
technologists who per tom antibody investigations infrequently. 
They can also be invaluable for experienced technologists 
performing complex investigations. When integrated with a 
computerized blood bank record-keeping system, antibody inves- 
tigation software can improve storage and retrieval of test results. 
Database applications for retrieving rare cells and sera offer the 
potential to improve the productivity and capability of any anti- 
body investigation laboratory And word processing applications 
greatly enhance the potential for generating meaningful reports 
of test results. Immunohematology 1993;9:53-55. 
Antibody investigation has generally been consid- 
ered to be as much an art as it is a science. It is con- 
sidered a science because the technologist must have 
an in-depth knowledge of blood group systems and of 
serologic reactions that can be expected with different 
antibodies, and an understanding of various serolog- 
ic techniques. It is considered an art because the tech- 
nologist needs problem-solving skills and patience to 
observe subtle differences in the test results obtained. 
Investigating blood group antibodies requires a log- 
ical pattern for evaluating the test results. However, 
investigations can become complex when several 
blood group specificities, antibodies to a high- 
incidence antigen, or autoantibodies are involved. 
The thought process must take into account the 
strengths of reactions, the phase(s) of reaction, and 
the antigenic makeup of the cells that do and do not 
react with the test serum. This thought process is 
often performed poorly by blood bank technolo- 
gists.1,2 Much of this logic lends itself to automation, 
because the rules to be followed can be programmed 
into the computer. These attempts to program logic 
are sometimes referred to as "artificial intelligence"' 
or "fuzzy logic." 
What can a computer do that a technologist cannot? 
Probably nothing, but it can perform some tasks more 
consistently For example, the computer will be more 
consistent in the way it interprets test results than if 
several technologists are involved in reviewing anti- 
body investigations.1,2 Even when one technologist 
is performing several investigations, he or she may 
handle individual investigations inconsistently-but 
this is not so with the computer.3 
For example, if the computer is programmed to 
indicate when antibodies to low-incidence antigens 
such as Kpa and Cw have not been excluded, the exclu- 
sions will be done in every case in which these anti- 
bodies have not been ruled out. Technologists often 
overlook these and other antibodies to low-incidence 
antigens because the antigens are often not on screen- 
ing cells, and are only occasionally on panel cells. 
The computer program interprets antibody inves- 
tigation test results using the rules established by the 
programmer. Because these rules vary only when the 
program is modified, the computer interpretation of 
test results is more consistent and objective. 
However, this feature can be a limitation because an 
experienced technologist often takes other factors 
into account-a process that can either improve the 
interpretation or lead the technologist astray 
Selecting a panel of cells to confirm or exclude anti- 
bodies can be a tedious chore when performed man- 
ually Insufficient exclusion of some antibodies and 
incomplete or inaccurate transcription of the antigen 
matrix can complicate the interpretation if a panel is 
prepared manually Panel cell selection can be han- 
dled quickly and easily by a computer. The computer 
can print antibody investigation worksheets, giving 
each cell donor's identification, blood group pheno- 
type, and cell suspension location, without making 
transcription errors.1,3 
The computer can also assist less experienced tech- 
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nologists in antibody investigation by offering an 
interpretation of the panel results or calculating the 
probability for each antibody specificity that has not 
been ruled out by the serologic reactions.’ The logic 
an experienced technologist uses when performing 
an antibody investigation can be duplicated by a com- 
puter program. The computer program can even dis- 
play suggestions for further investigation to resolve 
complex problems.4 
If test results are to be stored for later review or 
interpretation, the donor identification, specimen 
used, details of special methods, strength of reactions, 
etc. must he entered with the test results. Retrieval of 
the test results also can be easier with a 
In addition, a computer is more accurate and consis- 
tent in recording and storing results of investigations 
than most technologists. 
A number of antibody identitication programs have 
been developed. Some of these programs have been 
offered commercially, but most have been developed in- 
house by blood banker.1,3,4 A few of the programs 
have been integrated with existing computerized 
record-keeping systems.3 The approach that is taken by 
each programmer depends on the aspects of the anti- 
body investigation that the programmer feels will bene- 
fit most from computer assistance. For example, some 
programmers take into account the patient’s racial ori- 
gin and/or red cell phenotype. Other programmers do 
not consider these variables, since they can lead to con- 
fusion when interpreting results of autoantibody with 
specificities mimicking alloantibodies. 
What role will computers play in antibody investi- 
gation in the future? This is a difficult question to 
answer. Six years ago, we started to develop antibody 
investigation software in-house. Our program now 
offers these features: 
Data for commercial or in-house panels can be 
stored on-line. 
Donor identifications and cell phenotypes for 33 
antigens plus four user-specified antigens are 
maintained. 
Panels of selected red cells can he compiled by the 
computer, or a technologist can select and enter 
2 to 16 cells. Either selection can he viewed on 
the terminal, and cells can he deleted or added as 
desired (up to a maximum of 16 cells per panel). 
Panels that lack high-frequency antigens or that 
possess low-frequency antigens can he selected. 
Graded test results can be entered into the com- 
puter as the results are read, or panel worksheets 
can be printed and the test results recorded 
on the worksheet, then later entered into the 
computer. 
The computer can analyze the results of antibody 
investigation panels by performing exclusions and 
can then display the level of probability for anti- 
bodies that have not been ruled out. 
Each phase of testing is interpreted individually, 
so that mixtures of antibodies can he recognized 
more easily 
Antibody investigation test results can be stored 
on-line, and a hard copy showing panel cell 
phenotypes and the test results can he printed. 
A printout of the final antibody investigation 
(including the test results) can he printed on 
demand, or the results of antibody screen and 
panels can he reviewed on the computer screen. 
Results of all tests performed on a specific panel 
or on an individual panel cell can he analyzed (an 
important part of quality control of panel cells, 
serologic techniques, and interpretation of 
results). 
The antibody investigation software has been inte- 
grated with the routine software, allowing review 
of a patient’s test results, transfusion history, and 
the antibodies reported from the same computer 
terminal. 
A list of antibodies identified within a specified 
time range can be printed, or a list of all patients 
who have a specified antibody can be printed. 
With emerging technologies such as voice recogni- 
tion and bar coding, speed of data entry will improve 
and the time required for panel maintenance will he 
reduced. These advances should increase the level of 
acceptance by technologists. 
We know of several blood banks that have evaluat- 
ed antibody investigation software, but only a few are 
using the programs routinely. In spite of the many 
advantages, there is a lack of acceptance. From our 
experience, some of the reasons for this include the 
following: 
The amount of time necessary to enter and main- 
tain donor cell phenotypes and information about 
commercial panels is unacceptable. 
The response time of the computer to carry out 
the numerous computations to identify blood 
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group antibodies may also be unacceptable if the 
hardware is not very powerful. 
It takes longer to enter test results into the com- 
puter than it does to record them on paper. A 
payback on the time invested is not always seen, 
especially if it is not necessary to review the results 
later. 
The computer software sometimes selects more 
cells for follow-up panels than an experienced 
technologist would select. When this situation 
occurs, the technologist can manually select a cell 
panel or modify the computer-selected panel. 
Further enhancements to the “fuzzy logic” used by 
the computer to select panel cells may also help. 
For many of the programs, the lack of integration 
with computerized record-keeping systems is a 
disadvantage. 
Other applications for the computer in the anti- 
body investigation laboratory include organizing a 
library of frozen rare cells, sera, and fluids. Word- 
processing software is also an effective way of improv- 
ing the speed and accuracy of the reports generated 
following the antibody investigation. We have a 
library of about 50 antibody investigation reports that 
we modify with a word processor to explain the 
results of an investigation. This allows us to produce 
detailed reports quickly for the patient’s chart and the 
blood bank records.5 
We feel that antibody investigation is well suited to 
computerization. With continuing improvements to 
computer hardware and increasing familiarity of 
blood bank technologists with computer applications, 
there will be more interest in the use of computers in 
antibody investigation in the future. 
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